Bentham OPEN is committed to disseminating research and scholarly publications as widely as possible. It supports the principle that 'the results of research that have been publicly funded should be freely accessible in the public domain’ and therefore it encourages researchers to make their research available through Open Access (OA).
Open Access publishing is not without costs. To provide Open Access, Bentham OPEN journals partly defray the expenses of journal production, and online hosting and archiving from authors and their research sponsors by charging a article processing charges for each article they publish. The fees vary by journal.
The article processing charges for each article published in this journal is US $1005.
The following special discounts are offered to authors and editorial board members:
The article processing charges includes professional copy editing charges. Once the paper is accepted for publication, the author will receive an electronic invoice via email.
Extend the scope and visibility of your research by creating an animated abstract. Bentham OPEN has collaborated with Focus Medica, one of the world’s largest publishers of expert animated atlases and videos in medicine and science.
An animated abstract will help summarise the essential discoveries/ key findings of your published research or review article. Each professionally produced full-coloured animated abstract in video format (length 3-5 minutes) is accompanied by an English spoken or foreign language commentary. The animated abstract will be published online along with the published article.
The payment for an animated abstract will be US$ 1190 for English language, and US$ 1690 for Foreign language articles. Initially, an advance amount of US$ 700 will be payable to the Publisher to start work on the Animated Abstract, while the balance of US$ 490 (English language) or US$ 990 (Foreign language) will be payable on completion of the Animated Abstract.
Authors will be asked whether they wish to opt-in for the paid animated abstract service, and if not, the article will be published as normal Animated abstracts are available as Open Access (free viewing) for maximum visibility and awareness to readers at anytime, anywhere. The animated abstracts are licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License (CC BY-NC-ND 4.0) https://creativecommons.org/licenses/by-nc-nd/4.0/.
Antimicrobial resistance represents a significant challenge to future healthcare provision.An acronym ESKAPEE has been derived from the names of the organisms recognised as the major threats although there are a number of other organisms, notably Neisseria gonorrhoeae, that have become equally challenging to treat in the clinic. These pathogens are characterised by the ability to rapidly develop and/or acquire resistance mechanisms in response to exposure to different antimicrobial agents. A key part of the armoury of these pathogens is a series of efflux pumps, which effectively exclude or reduce the intracellular concentration of a large number of antibiotics, making the pathogens significantly more resistant. These efflux pumps are the topic of considerable interest, both from the perspective of basic understanding of efflux pump function, and its role in drug resistance but also as targets for the development of novel adjunct therapies. The necessity to overcome antimicrobial resistance has encouraged investigations into the characterisation of resistance-modifying efflux pump inhibitors to block the mechanisms of drug extrusion, thereby restoring antibacterial susceptibility and returning existing antibiotics into the clinic. A greater understanding of drug recognition and transport by multidrug efflux pumps is needed to develop clinically useful inhibitors, given the breadth of molecules that can be effluxed by these systems. This review discusses different bacterial EPIs originating from both natural source and chemical synthesis and examines the challenges to designing successful EPIs that can be useful against multidrug resistant bacteria.
Bentham OPEN offers a discount of 50% on the Publication Fee for manuscripts of all corresponding authors who reside in countries which are categorized as low-income economies by the World Bank. To see if you qualify for the discount, please refer to the complete list of these countries click here.
Please remember that requests for waivers or discounts should be made during the initial submission process, not after an article has been accepted. This process is not involving editors, and the ability to pay does not influence editorial decisions. Payment is not required unless and until the author's article is accepted. Articles that have been accepted will not be published until payment has been received. Bentham Science does not refund the Publication Fee once it has been paid.
If Bentham Science genuinely believes that the article should not be published, we reserve the right to decline publication and refund the Publication Fee.
If Bentham genuinely believes that the article should be retracted or removed from our website, for example, due to a breach of author warranties, we are under no obligation to refund the Publication Fee. The Publication Fee will not be refunded when articles are retracted due to author error or misconduct.
Delays caused by editorial decisions or author changes are a normal part of the publishing process.
If author cancel an order for any Product(s) within 14 days of receiving the Product(s), or before we ship the Product(s), any refund will be for the amount author paid for the Product(s), including any basic delivery charge; author will be responsible for any additional delivery costs, such as urgent delivery service, as well as the cost of returning the Product(s) to us.